SNRNP70 and extranodal nasal NK/T cell lymphoma: 3) We were unable to validate the relationship between RETSAT and SNRNP70 and the prognosis of immunotherapy in patients in the GI-NKTCL cohort due to the lack of survival data for immunotherapy in the GI-NKTCL cohort.